Education
About Us
Working with TipRanks
Follow Us
Sagimet Biosciences, Inc. Class A (SGMT)
NASDAQ:SGMT
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 2.00M | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 2.00M | $ 0.00 | $ 0.00 |
| Operating Income | $ -56.89M | $ -54.45M | $ -30.74M | $ -31.05M | $ -23.72M |
| EBITDA | $ -56.89M | $ -45.57M | $ -30.74M | $ -31.05M | $ -23.72M |
| Net Income | $ -51.04M | $ -45.57M | $ -27.88M | $ -30.50M | $ -24.44M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 113.12M | $ 151.25M | $ 94.90M | $ 32.34M | $ 56.73M |
| Total Assets | $ 116.48M | $ 160.26M | $ 96.72M | $ 33.03M | $ 59.03M |
| Total Debt | $ 78.00K | $ 78.00K | $ 65.00K | $ 211.00K | $ 348.00K |
| Net Debt | $ -34.94M | $ -75.76M | $ -75.07M | $ 53.00K | $ -56.38M |
| Total Liabilities | $ 5.10M | $ 4.45M | $ 5.65M | $ 219.98M | $ 217.29M |
| Stockholders' Equity | $ 111.38M | $ 155.81M | $ 91.06M | $ -186.95M | $ -158.26M |
| Cash Flow | |||||
| Free Cash Flow | $ -45.65M | $ -42.44M | $ -23.77M | $ -24.49M | $ -21.71M |
| Operating Cash Flow | $ -45.65M | $ -42.44M | $ -23.77M | $ -24.49M | $ -21.71M |
| Investing Cash Flow | $ 4.56M | $ -61.68M | $ 12.58M | $ -32.01M | $ 0.00 |
| Financing Cash Flow | $ 275.00K | $ 104.82M | $ 86.17M | $ -73.00K | $ 9.74M |